
Supplements and Featured Publications
- Definitive Management of Head Lice in the Era of Pediculicide Resistance
- Volume 10
- Issue 9 Suppl
PARTICIPATING FACULTY
The American Journal of Managed Care
This supplement to contains information on themanagement and treatment of head lice and is based on a teleconference that was held on May26, 2004. It has been peer reviewed by an expert in the field.
Moderator
Barbara L. Frankowski, MD, MPH
University of Vermont
Medical Center Hospital of Vermont Campus
University Pediatrics
Faculty
Ronald C. Hansen, MDProfessor, Internal Medicine (Dermatology)
University of Arizona Health Sciences Center
President
Miami, Florida
Sally Z. Schoessler, BSN, RN, SNT
Sherman Elementary School Teacher
Henrietta, New York
Dennis P. West, PhD, FCCP
Department of Dermatology and
Institutional Review Board
Chicago, Illinois
Elliot F. Ellis, MD
University of South Florida
Faculty Disclosure
The American Journal of Managed Care
It is the policy of to have all faculty who participate in programssponsored by corporate organizations disclose any real or apparent conflicts of interest.
The following faculty have reported relationships with the following corporate organizations:
- Elliot F. Ellis, MDConsultant For: Odyssey Pharma TaroPharma
- Terri L. Meinking, BAGrant/Research Support From/Consultant To:Summers LabsConsultant To: HachTech The Medical Letter XL TechnologiesGrant/Research Support From/Speaker For: TaroPharma
The following faculty report no relationships with any corporations:
- Barbara L. Frankowski, MD, MPH
Sally Z. Schoessler, BSN, RN, SNTThe following faculty did not submit disclosure information:
- Ronald C. Hansen, MD
Dennis P. West, PhD, FCCP
The American Journal of Managed Care
Signed disclosures are on file at the offices of , Jamesburg, New Jersey.
This program is supported by Procter & Gamble Pharmaceuticals and Aventis Pharmaceuticals.
The contents of this supplement may include information regarding the use of products that may beinconsistent with or outside the approved labeling for these products in the United States.Physicians should note that the use of these products outside current approved labeling is consideredexperimental and are advised to consult prescribing information for these products.
Articles in this issue
about 21 years ago
Clinical Update on Resistance and Treatment of Pediculosis capitisabout 21 years ago
Treating and Managing Head Lice: The School Nurse Perspectiveabout 21 years ago
Head Lice Treatment Costs and the Impact on Managed Careabout 21 years ago
Overview: The State of Head Lice Management and ControlNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.